摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1R,2S,6R,7aR)-1,2,6-trihydroxyhexahydro-1H-pyrrolizin-3-one | 1604804-42-3

中文名称
——
中文别名
——
英文名称
(1R,2S,6R,7aR)-1,2,6-trihydroxyhexahydro-1H-pyrrolizin-3-one
英文别名
(1R,2S,6R,8R)-1,2,6-trihydroxy-1,2,5,6,7,8-hexahydropyrrolizin-3-one
(1R,2S,6R,7aR)-1,2,6-trihydroxyhexahydro-1H-pyrrolizin-3-one化学式
CAS
1604804-42-3
化学式
C7H11NO4
mdl
——
分子量
173.169
InChiKey
HESYNJWUSQYCCC-KAZBKCHUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -2.2
  • 重原子数:
    12
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.86
  • 拓扑面积:
    81
  • 氢给体数:
    3
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    (1R,2S,6R,7aR)-1,2,6-trihydroxyhexahydro-1H-pyrrolizin-3-one 在 aluminium hydride 作用下, 以 四氢呋喃 为溶剂, 反应 3.0h, 以80%的产率得到(1R,2R,6R,7aR)-1,2,6-trihydroxyhexahydro-1H-pyrrolizine-1,2,6-triol
    参考文献:
    名称:
    An asymmetric substrate-controlled Morita–Baylis–Hillman reaction as approach for the synthesis of pyrrolizidinones and pyrrolizidines
    摘要:
    We describe herein an approach to the total synthesis of functionalized pyrrolizidinones and pyrrolizidines. The synthetic sequence is based on a highly stereoselective substrate-controlled Morita-Baylis-Hillman (MBH) reaction between a chiral amino-aldehyde and methyl acrylate. The selectivity attained in this reaction was controlled by the presence of a hydroxyl group adequately placed in the structure of the amino-aldehyde used as the nucleophilic component of the MBH reaction. The MBH adducts were used as substrate for an efficient total synthesis of pyrrolizidinones and pyrrolizidines in good overall yield. (C) 2013 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tet.2013.10.050
  • 作为产物:
    参考文献:
    名称:
    An asymmetric substrate-controlled Morita–Baylis–Hillman reaction as approach for the synthesis of pyrrolizidinones and pyrrolizidines
    摘要:
    We describe herein an approach to the total synthesis of functionalized pyrrolizidinones and pyrrolizidines. The synthetic sequence is based on a highly stereoselective substrate-controlled Morita-Baylis-Hillman (MBH) reaction between a chiral amino-aldehyde and methyl acrylate. The selectivity attained in this reaction was controlled by the presence of a hydroxyl group adequately placed in the structure of the amino-aldehyde used as the nucleophilic component of the MBH reaction. The MBH adducts were used as substrate for an efficient total synthesis of pyrrolizidinones and pyrrolizidines in good overall yield. (C) 2013 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tet.2013.10.050
点击查看最新优质反应信息

文献信息

  • An asymmetric substrate-controlled Morita–Baylis–Hillman reaction as approach for the synthesis of pyrrolizidinones and pyrrolizidines
    作者:Kristerson R. Luna-Freire、João Paulo S. Scaramal、Jackson A.L.C. Resende、Cláudio F. Tormena、Fábio L. Oliveira、Ricardo Aparicio、Fernando Coelho
    DOI:10.1016/j.tet.2013.10.050
    日期:2014.5
    We describe herein an approach to the total synthesis of functionalized pyrrolizidinones and pyrrolizidines. The synthetic sequence is based on a highly stereoselective substrate-controlled Morita-Baylis-Hillman (MBH) reaction between a chiral amino-aldehyde and methyl acrylate. The selectivity attained in this reaction was controlled by the presence of a hydroxyl group adequately placed in the structure of the amino-aldehyde used as the nucleophilic component of the MBH reaction. The MBH adducts were used as substrate for an efficient total synthesis of pyrrolizidinones and pyrrolizidines in good overall yield. (C) 2013 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

颈花脒 罗拉西坦 矛裂碱 甲基六氢-1H-吡咯里嗪-1-羧酸酯 瓶千里光碱N-氧化物 新瓶草千里光碱 异款冬碱 季普拉嗪 四氢-1H-吡咯里嗪-2(3H)-酮 四氢-1H-吡咯烷-7a(5H)-乙酸 四氢-1H-吡咯并吡咯烷-7a(5H)-乙胺二盐酸盐 四氢-1H-吡咯嗪-7a(5h)-乙酸乙酯 响铃豆碱 去甲一叶秋碱 六氢-吡咯嗪-1-酮 六氢-3-(羟甲基)-1H-吡咯里嗪-1,2,7-三醇 六氢-1H-吡咯里嗪-2-羧酸 六氢-1H-吡咯里嗪 六氢-1H-吡咯嗪-7A-甲腈 倒千里光裂醇 二[[(1R,8R)-2,3,5,6,7,8-六氢-1H-吡咯里嗪-1-基]甲基]2,4-二(4-羟基苯基)环丁烷-1,3-二羧酸酯 [(1S,8R)-2,3,5,6,7,8-六氢-1H-吡咯里嗪-1-基]甲醇 [(1S,7R,8R)-7-[(Z)-2-甲基丁-2-烯酰基]氧基-2,3,5,6,7,8-六氢-1H-吡咯里嗪-1-基]甲基 (Z)-2-(羟基甲基)丁-2-烯酸酯 7a-乙氧基-7,7-二甲基六氢-3H-吡咯里嗪-3-酮 7Alpha-双稠吡咯啶-乙酸盐酸盐 7Alpha-双稠吡咯啶-乙腈 7-甲基六氢-1H-吡咯里嗪-1-酮 7,8-二羟基-4'-甲氧基异黄酮 5-甲氧羰基甲基-1-氮杂双环[3.3.0]辛烷 5-氧代六氢-1H-吡咯里嗪-1-甲醛 5-(2-氨基乙基)-1-氮杂双环[3.3.0]辛烷 2,3,5,6,7,8-六氢-1H-吡咯里嗪-1-胺 1-氮杂二环[2.2.1]庚烷,3-(5-异[口噁]唑基)-,外-(9CI) (六氢-1H-吡咯里嗪-7A-基)甲胺 (Z)-2-甲基-2-丁烯酸[(1S,2R,7aS)-六氢-1-羟基甲基-1H-吡咯里嗪-2-基]酯 (Z)-2-甲基-2-丁烯酸[(1S,2R,7aR)-六氢-2beta-羟基-1H-吡咯里嗪-1beta-基]甲基酯 (7aS)-六氢-3H-吡咯里嗪-3-酮 (7aS)-2-甲基四氢-1H-吡咯里嗪-1,3(2H)-二酮 (7R,7aR)-7-异丙基六氢-3H-吡咯里嗪-3-酮 (2S,3S)-2,3-二羟基-2-异丙基丁酸[(1R,7aalpha)-六氢-1H-吡咯里嗪-1-基]甲基酯 (2S,3R)-2,3-二羟基-2-异丙基丁酸[(1R,7aR)-六氢-1H-吡咯里嗪-1-基]甲基酯 (2S,3R)-2,3-二羟基-2-异丙基丁酸 [(1R,7aS)-2,3,5,6,7,7a-六氢-1H-吡咯里嗪-1-基]甲酯 (1S-(1alpha,2alpha,7aalpha))-六氢-2-羟基-2-甲基-1H-吡咯里嗪-1-羧酸甲酯 (1R,8S)-3-氧代-1,2,5,6,7,8-六氢吡咯里嗪e-1-甲醛 (1R,8S)-1-甲基六氢-1H-吡咯嗪 (1R,8R)-7-亚甲基-1,2,3,5,6,8-六氢吡咯里嗪-1-醇 (1R,7aS)-1-[[[(2S,3R)-2,3-二羟基-2-异丙基丁酰基]氧基]甲基]六氢-1H-吡咯里嗪4-氧化物 (1R,7S,8R)-7-(羟基甲基)-2,3,5,6,7,8-六氢-1H-吡咯里嗪-1-醇 (1R,6S,7S,8R)-7-(羟甲基)-2,3,5,6,7,8-六氢-1H-吡咯嗪-1,6-二醇 (1R,2R,3R,7S,8S)-3-(羟基甲基)-2,3,5,6,7,8-六氢-1H-吡咯里嗪-1,2,7-三醇